BERLIN-CHEMIE Menarini’s new frontier of podcast communication

BERLIN-CHEMIE Menarini, the German company part of the Menarini Group, launched an innovative and original initiative in September 2020: The weekly podcast “EinBlick – Der Podcast” (a play on the words ein Blick, a glance, and Einblick, insight), that addresses topics in health policy, pharmaceutical policy and digital health. The podcast is one of today’s []

trending_flat Read more

Menarini’s commitment to help the less privileged beyond all borders

The development of a socially responsible corporate culture is achieved through the promotion of both cultural and solidarity initiatives. For many years, the Menarini Group has been actively involved in sponsoring poverty alleviation campaigns, supporting sustainable lifestyles and promoting the projects of local and regional communities near the Group’s production and research centres. Several of []

trending_flat Read more

By marking #BPDCNday, Menarini Group is giving a rare and aggressive blood cancer nowhere to hide

Together, we make a difference Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare hematologic malignancy that often manifests with skin lesions. Although BPDCN is mostly diagnosed in elderly patients, it may occur at any age,1,2 with men three times more likely to be affected than women. There are roughly 700 cases in the United []

trending_flat Read more

The Fondazione Internazionale Menarini looks to the future with two new digital initiatives

Established in 1976, the “Fondazione Internazionale Menarini” aims to promote research and knowledge in the fields of biology, pharmacology and medicine, as well as economics and human sciences, throughout the world. In the words of Sergio Gorini, the Foundation’s first president, the Institution is conceived as “a meeting point for all friends with common ideals []

trending_flat Read more

Menarini Asia Pacific celebrates its 10 Years Anniversary

Founded in 1886, the Menarini Group is Italy’s largest pharmaceutical company, with over 17,000 employees worldwide, a consolidated turnover of almost 4 billion euros in 2020 and a great number of strategically located offices in various parts of the world that act as a reference point for the surrounding markets. Among these, Menarini’s Asia-Pacific division []

trending_flat Read more

Menarini launches “Infection in Focus” portal to fight antimicrobial resistance

Ever since penicillin was discovered in 1928, antibiotics, medicines used to prevent and treat bacterial infections, have made an enormous contribution to global health and diseases that were once deemed to be fatal have been successfully treated for decades. The development of antibiotics is recognised as one of the greatest advances in therapeutic medicine. Antibiotics []

trending_flat Read more